Nisa Investment Advisors
ACOR

Nisa Investment Advisors’s Acorda Therapeutics ACOR Stock Holding History

Nisa Investment Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2
Closed -$1K – 2050
2019
Q3 		$1K Hold
2
– – ﹤0.01% 2005
2019
Q2 		$2K Hold
2
– – ﹤0.01% 1990
2019
Q1 		$4K Hold
2
– – ﹤0.01% 1955
2018
Q4 		$4K Hold
2
– – ﹤0.01% 1861
2018
Q3 		$5K Hold
2
– – ﹤0.01% 1881
2018
Q2 		$8K Hold
2
– – ﹤0.01% 1787
2018
Q1 		$7K Buy
+2
New +$5.99K ﹤0.01% 1751
2017
Q2 		– Sell
-27
Closed -$67K – 1871
2017
Q1 		$67K Sell
27
-1
-4% -$2.88K ﹤0.01% 1410
2016
Q4 		$62K Hold
28
– – ﹤0.01% 1409
2016
Q3 		$69K Hold
28
– – ﹤0.01% 1375
2016
Q2 		$84K Hold
28
– – ﹤0.01% 1343
2016
Q1 		$90K Buy
+28
New +$116K ﹤0.01% 1347
2014
Q1 		– Sell
-93
Closed -$327K – 1347
2013
Q4 		$327K Buy
+93
New +$363K ﹤0.01% 1146

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Nisa Investment Advisors's ACOR Position: Q4 2019 in Review

Nisa Investment Advisors sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 2 shares — an estimated $1K sold.

Nisa Investment Advisors first reported a position in ACOR in Q4 2013 and held it in 13 quarters. The position peaked at $327K in Q4 2013. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Nisa Investment Advisors reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Nisa Investment Advisors sold 2 Acorda Therapeutics shares in Q4 2019, an estimated $1K.
  • Nisa Investment Advisors first reported a position in Acorda Therapeutics in Q4 2013 and held it in 13 quarters.
  • Nisa Investment Advisors's Acorda Therapeutics position peaked at $327K in Q4 2013.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Nisa Investment Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.